Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a to help health care providers and families locate formula.
Related News Articles
Headline
The American College of Obstetricians and Gynecologists April 17 released guidance recommending a new approach to prenatal care delivery. The guidance calls…
Headline
The National Institutes of Health April 7 released a study that found twins — smaller at birth on average than singletons — develop slower in early pregnancy…
Headline
A National Institutes of Health study published April 2 found that blood pressure patterns observed during the first half of pregnancy can determine a woman's…
Headline
The U.S. birth rate fell 2% in 2023 to about 3.6 million, according to final data released March 18 by the Centers for Disease Control and Prevention. The…
Headline
A study by the Penn State Department of Nutritional Sciences found that low vitamin D levels in the first trimester of pregnancy are associated with higher…
Headline
The U.S. maternal mortality rate decreased to 18.6 deaths per 100,000 live births in 2023, down from 22.3 in 2022, according to new data from the Centers for…